L-Asparaginase lowers plasma antithrombin and mannan-binding-lectin levels: Impact on thrombotic and infectious events in children with acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

L-Asparaginase lowers plasma antithrombin and mannan-binding-lectin levels: Impact on thrombotic and infectious events in children with acute lymphoblastic leukemia

Published:2015-03-27 Issue:8 Volume:62 Page:1381-1387
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Merlen Clémence¹,Bonnefoy Arnaud¹,Wagner Eric²,Dedeken Laurence³,Leclerc Jean-Marie¹,Laverdière Caroline¹,Rivard Georges-Etienne¹

Affiliation:

1. Division of Hematology / Oncology; CHU Sainte-Justine; Montréal QC Canada

2. Immunology / Histocompatibility laboratory; CHU de Quebec and Department of Microbiology; Infectious Diseases and Immunology; Laval University; Quebec QC Canada

3. Department of Hematology and Oncology; Hôpital Universitaire des Enfants Reine Fabiola; Université Libre de Bruxelles; Belgium

Funder

Bayer's funds

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.25515/fullpdf

Reference50 articles.

1. Long-term results of Dana-Farber Cancer Institute (DFCI) ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000);Silverman;Leukemia,2010

2. Use of L-asparaginase in childhood ALL;Muller;Crit Rev Oncol Hematol,1998